Please select your view
Professor O’Toole is recognised as one of Australia’s leading molecular pathologists, with major research and diagnostic interests in breast cancer as well as the molecular pathology of melanoma and lung cancer. She was an expert member of the working group for Cancer Australia on Influencing Best Practice in Breast Cancer and is a National Breast Cancer Foundation Practitioner Fellow.
Professor O’Toole is Clinical Professor at Sydney Medical School and head of Breast Cancer Translational Research at the Garvan Institute of Medical Research where she collaborates with researchers and clinicians nationally and internationally to promote the rapid translation of scientific discoveries. Her work has appeared in more than 100 scientific publications and she has secured over $20 million in research funding as a chief investigator. She is Chair of Cancer Services for the Royal College of Pathologists of Australasia.
Her areas of interest include Molecular Pathology, Breast Pathology and GIT/Hepatobiliary Pathology. She is FRCPA and holds MB, BS (Hons I and the University Medal), BSc Med (Hons I and recipient of the Prize for Experimental Pathology) and a PhD.
Dr Mirette Saad is a Chemical Pathologist and the National Clinical Director of the Molecular Genetic Pathology at Australian Clinical Labs.
Dr Saad’s current professional interests are continuing development in Molecular Genetics and Chemistry. In addition to her daily work to provide a comprehensive Chemical Pathology testing service, she currently medically supervises the Molecular Genetic testing for non-invasive prenatal testing (NIPT), hereditary disorders, personalised drug therapy and cancer. She is working closely with Health Practitioners and the laboratory team to employ the knowledge and identify opportunities to provide the best diagnostic services which include interpretation of results and the provision of important consultative advice to doctors in assisting with the management plans of patients.
Dr David Deam has played an active role in teaching scientific, nursing and medical staff at both undergraduate and postgraduate levels and has been an examiner for the Australasian Association Of Clinical Biochemists as well as the Royal College of Pathologists of Australasia. Dr Deam’s research interests and publications include work on thyroid function testing, various aspects of diagnostic protein measurement and the rational use of biochemical tests. His special interests include testing of endocrine function; protein abnormalities; as well as laboratory automation and application of computing to pathology services. He is currently working as a Chemical Pathologist and is the Medical Head of Department at Australian Clinical Labs.
Dr Nirenberg graduated in medicine from the University of Melbourne. His training in pathology included rotations at St Vincent's Hospital, The Royal Women's Hospital and the Peter MacCallum Cancer Institute. In addition to Fellowships of the Royal College of Pathologists of Australasia and the Royal College of Pathologists (UK) he has a post-fellowship Diploma in Dermatopathology.
He has wide experience in both the public and private sectors, and is involved in teaching medical students and doctors. He is a panel member of the Avant Medical Experts Committee and is a Director of the Australasian Dermatopathology Society.
Assoc. Prof. Hemmings worked in Auckland, Christchurch and Canberra and undertook sabbatical fellowships in London and Boston. Dr Hemmings has subspecialty expertise in soft tissue, gastrointestinal, and head, neck and endocrine pathology and she has a particular interest in rare cancers including sarcoma, neuroendocrine tumours and GIST, and in tumour biology as it informs the multidisciplinary management of cancer. She belongs to several professional interest groups in these areas, including COSA, AGITG, ASSG, ENETS, ANZNET and the European Society of Pathology. Dr Hemmings serves on the ASSG Scientific Advisory Committee, the WA Colorectal Tumour Collaborative Group and the Clinical Advisory Group of the National Bowel Cancer Screening Programme, and she is a founding member and foundation Secretary/Treasurer of the Australasian Gastrointestinal Pathology Society.
Clinical Labs has invested in cutting edge technology with the acquisition of the Roche Cobas c513 Analyser
Clinical Labs proudly sponsored the World’s Longest Lunch held on the Geelong Waterfront today.
Australian Clinical Labs and Myriad Genetics were pleased to host key Breast Surgeons and Oncologists at exclusive events.
Australian Clinical Labs was proud to once again sponsor Cyrenian House’s annual charity golf day at Meadow Springs Golf Club.